Digital Measures of Neuropsychological Tests in AD patients - Digital Measures of Neuropsychological Tests

Philips Research0 个研究点目标入组 160 人开始时间: 待定最近更新: 2024年2月28日

适应症

试验速览

暂无简介。

•For AD patient:
•1. Aged 18 and older
•2. Fluent/correct speaker in Dutch
•3. AD patient is able to give consent
•4. AD diagnosis by a clinical specialist, such as a geriatrician or neurologist
•5. Being able to perform the neuropsychological tests with an Ipad
•6. AD patient living at home (not at a nursing home)
•7. Date of AD diagnosis < 2yr;For healthy participant:
•1. Partner of relative of a patient with AD
•2. Fluent/correct speaker in Dutch
•3. Able to provide informed consent
•4. Aged 18 and older

•For AD patient;
•1. Unable or incompetent to give written informed consent
•2. Severe communication deficits
•3. Unable and/or unwilling to use a tablet to perform the tests
•4. Medical history of neurological and/or psychiatric disorders (except for AD)
•5. Mild Cognitive Impairment (MCI), vascular dementia, frontotemporal or mixed dementia diagnosis
•6. Traditional neuropsychological assessment in the last 6 months
•7. Bad eyesight or hearing, even with correction
•8. Unable to properly use hands
•9. An average alcohol consumption of 4 or more units per day
•10. Use of one or more of the following types of medicine: antipsychotics, benzodiazepines, antidepressants, opioids, lithium, anti-epileptics, anti- Parkinson medication
•11. Use of drugs;For healthy participant:
•1. Unable or incompetent to give written informed consent
•2. Medical history of neurological and/or psychiatric disorders
•3. Traditional neuropsychological assessment in the last 6 months
•4. Bad eyesight or hearing, even with correction
•5. Unable to properly use hands
•6. An average alcohol consumption of 4 or more units per day
•7. Use of one or more of the following types of medicine: antipsychotics, benzodiazepines, antidepressants, opioids, lithium, anti-epileptics, anti- Parkinson medication
•8. Use of drugs

发起方